https://andro.io/app/staging-jpi5
Power 100
Android app profile
sinCephalea Staging for Android – Latest Version & Features
by Perfood GmbH
★★★★★
(0 ratings)
Rate this app
How do you feel about sinCephalea Staging?
Thanks for your feedback!
> 2.2k
Monthly Downloads
~$900
Estimated Cost
Screenshots
About sinCephalea Staging
sinCephalea is a digital therapy for the prophylaxis of migraine attacksThe aim is to reduce postprandial blood sugar variability through personalized dietary recommendations.FUNCTIONS- Determination of the personalized low glycemic diet- food diary- Comprehensive medical history- Evaluation report for treating specialist groups- Continuous support through knowledge lessons- Free supportAPPLICATION INDICATIONsinCephalea can be used to support the prophylaxis of migraine attacks according to the diagnosis code ICD-10 code G43.- or class 1 of the IHS classification ICHD-3.SinCephalea is ideal for you if:- you suffer from migraines an average of at least three days per month- you want to improve your migraines without medication- you are ready for digital, independent migraine therapy and want to implement individual dietary recommendationsNOTICE MEDICAL DEVICE AND MEDICAL INTENDED USEIn connection with a correspondingly marked guide (e.g.
"sinCephalea"), this app represents a medical product of risk class I according to Annex IX of Directive 93/42 / EEC.sinCephalea supports the prophylaxis of migraine attacks.
The basis is the modulation of the postprandial blood sugar response through personalized low-glycemic diet recommendations.
Affected users receive a report that evaluates the meals consumed during a previous test phase with regard to their postprandial blood sugar response.
From this assessment, nutritional recommendations are derived which, if adhered to, can reduce postprandial blood sugar fluctuations.
This ensures a sufficient supply of energy to the brain via glucose and has a positive influence on local inflammatory processes.INFORMATIONInformation on the suitable target group, contraindications, data protection declaration and further details on sinCephalea:https://www.sincephalea.de
"sinCephalea"), this app represents a medical product of risk class I according to Annex IX of Directive 93/42 / EEC.sinCephalea supports the prophylaxis of migraine attacks.
The basis is the modulation of the postprandial blood sugar response through personalized low-glycemic diet recommendations.
Affected users receive a report that evaluates the meals consumed during a previous test phase with regard to their postprandial blood sugar response.
From this assessment, nutritional recommendations are derived which, if adhered to, can reduce postprandial blood sugar fluctuations.
This ensures a sufficient supply of energy to the brain via glucose and has a positive influence on local inflammatory processes.INFORMATIONInformation on the suitable target group, contraindications, data protection declaration and further details on sinCephalea:https://www.sincephalea.de